Staging and functional characterization of pheochromocytoma and paraganglioma by 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography. - Wikidata - wikimedia - TriplyDB

Staging and functional characterization of pheochromocytoma and paraganglioma by 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography.

Staging and functional characterization of pheochromocytoma and paraganglioma by 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography.

http://www.wikidata.org/entity/Q35925505

about

Connecting molecular pathways to hereditary cancer risk syndromes Pheochromocytoma in Urologic Practice Current views on cell metabolism in SDHx-related pheochromocytoma and paraganglioma Multiple Recurrent Paraganglioma in a Pediatric Patient with Germline SDH-B Mutation.Renaissance of (18)F-FDG positron emission tomography in the imaging of pheochromocytoma/paraganglioma.Mitochondrial Deficiencies in the Predisposition to Paraganglioma Marker-Negative Pheochromocytoma Associated with Inferior Vena Cava Thrombosis Pheochromocytoma and paraganglioma: diagnosis, genetics, management, and treatment Association of urinary bladder paragangliomas with germline mutations in the SDHB and VHL genes.Succinate dehydrogenase gene mutations in cardiac paragangliomas Superiority of [68Ga]-DOTATATE PET/CT to Other Functional Imaging Modalities in the Localization of SDHB-Associated Metastatic Pheochromocytoma and Paraganglioma.Endocrine hypertension: An overview on the current etiopathogenesis and management options.Magnetic resonance spectroscopy of paragangliomas: new insights into in vivo metabolomics 18F-FLT PET/CT in the Evaluation of Pheochromocytomas and Paragangliomas: A Pilot Study.EANM 2012 guidelines for radionuclide imaging of phaeochromocytoma and paraganglioma.Radiopharmaceuticals in paraganglioma imaging: too many members on board?68Ga-DOTATATE PET/CT in the Localization of Head and Neck Paragangliomas Compared with Other Functional Imaging Modalities and CT/MRI Functional characterization of nonmetastatic paraganglioma and pheochromocytoma by (18) F-FDOPA PET: focus on missed lesions.Genotype-specific abnormalities in mitochondrial function associate with distinct profiles of energy metabolism and catecholamine content in pheochromocytoma and paraganglioma.(68)Ga-DOTATATE and (18)F-FDG PET/CT in Paraganglioma and Pheochromocytoma: utility, patterns and heterogeneity.Current and future trends in the anatomical and functional imaging of head and neck paragangliomas.Metastatic pheochromocytoma to liver without elevation of metanephrines and catecholamines.18F-FDG PET/CT as a predictor of hereditary head and neck paragangliomas Unexpected FDG-PET uptake in the gastrointestinal tract: endoscopic and histopathological correlations.Pathophysiology and diagnosis of disorders of the adrenal medulla: focus on pheochromocytoma.Diagnosis and preoperative imaging of multiple endocrine neoplasia type 2: current status and future directions.Paraganglioma and phaeochromocytoma: from genetics to personalized medicine.The incremental benefit of functional imaging in pheochromocytoma/paraganglioma: a systematic review.Metastatic pheochromocytoma and paraganglioma.Update on Modern Management of Pheochromocytoma and Paraganglioma.Genetic status determines (18) F-FDG uptake in pheochromocytoma/paraganglioma.Precision medicine in pheochromocytoma and paraganglioma: current and future concepts.Episodic Hypertension With an Adrenal Mass: A Red Herring.PET/CT comparing (68)Ga-DOTATATE and other radiopharmaceuticals and in comparison with CT/MRI for the localization of sporadic metastatic pheochromocytoma and paraganglioma.Role of positron emission tomography imaging in Multiple Endocrine Neoplasia syndromes.Diagnosing endocrine hypertension: a practical approach.Multifocal Head and Neck Paraganglioma Evaluated with Different PET Tracers: Comparison Between Fluorine-18-Fluorodeoxyglucose and Gallium-68-Somatostatin Receptor PET/CT.The value of a rapid contrast-enhanced angio-MRI protocol in the detection of head and neck paragangliomas in SDHx mutations carriers: a retrospective study on behalf of the PGL.EVA investigators.Integrated whole-body PET/MRI with 18F-FDG, 18F-FDOPA, and 18F-FDA in paragangliomas in comparison with PET/CT: NIH first clinical experience with a single-injection, dual-modality imaging protocol.Clinical course and prognostic factors in patients with malignant pheochromocytoma and paraganglioma: A single institution experience.

P2860

Q28291516-71545C5E-AD6E-4E6A-BB50-395B03DF7EF1 Q30365937-B1EF819E-685C-45F9-83BE-0888E3EB36C0 Q33590969-38ABF7AE-5650-49DC-BC31-050CDAA94DAA Q33611852-4E4FC5CD-5453-4593-891C-AD77C6511ADD Q33837098-01FC941F-D9FD-4125-8C54-EE6635CBEDEC Q33844924-04F63424-65D5-428A-8927-70292A26EEF5 Q33862258-693C89F8-94B6-42D7-A6AF-52D60931D380 Q34410500-A6EF9DFB-FA79-4AB9-9D92-C12CE2AF65CC Q35562799-E04A95BD-7C83-4335-9924-7AF5E5D043C7 Q35668495-D18ACD37-0F96-4960-AAFA-D8E55FC4DD34 Q36021577-DB3E3086-B6DF-42C1-BD38-F566E666030B Q36092390-6B520AA4-1C70-4DED-812B-F355B004789C Q36174425-89B39ED4-822B-4E5B-A2E9-111C3B36E13E Q36342833-D742A5CD-9400-4550-818F-727E05A0019E Q36467722-F4901F3D-373F-4419-9296-0B9A1A0852C7 Q36522039-35AA142D-AF8A-4837-9323-C97C019D4F48 Q36535747-2D16F07C-2EEB-4CFC-AB69-9B3D2AF61623 Q36724520-FD2D3CD6-D957-4039-850D-4EF84DDA44C3 Q37025126-5FC140F5-72CF-4092-99FC-BC4869AE55A0 Q37185143-A652C0DE-7E72-4407-A4ED-D469DB31F2D7 Q37220182-31A2565D-9B4C-4ED2-934C-15DE46E7FBA6 Q37399102-27409063-F3E6-4C7D-AD3C-F8C2DB723490 Q37640218-C7946BBD-C9B0-4452-9095-8C092B5FF2D3 Q37708042-7F1FA8DC-C4FA-46A8-B0C8-2F68343EAC3F Q38203226-D3ADFF3A-8BFB-48C8-B2B8-1E842C8CB385 Q38217012-9E63C9D4-9BDF-4804-BD90-D0C51BD69FD0 Q38266745-50BFF648-27E0-4971-9769-D92D44F9C690 Q38348673-D5DE889E-A0CC-4790-B6AB-F4389DE76342 Q38548784-EB735756-2EFC-4A80-A82B-8BC613F65736 Q38661522-8A7269C2-F97E-4A8E-AFD4-25349E871127 Q38741404-675CA0D1-C1A0-47DA-8DAA-BCDF26E9F327 Q38831451-0C9A3907-B9D3-4FFE-8E00-8BB00C2C49BF Q38833916-8EA71817-B7D4-4D9E-8552-A436C8D56005 Q38892571-42F3B643-5791-4F99-B248-9B73F21B72E4 Q38966288-1B9280AF-E81E-4C6C-BA62-D3A7993137E9 Q39337899-E233BE3A-659D-4A46-AEF3-5A275EEB5B0D Q39974881-FFCDA8C1-5D40-4AE8-B764-C8DA4B441D4D Q40477107-6F85A68F-32EF-4800-970A-6E3CB065B509 Q41207387-E4648133-D466-467D-9F9B-27F639BEE7A3 Q41225447-E210FBFB-7E88-4284-B87C-61F03F65E1E7

P2860

Staging and functional characterization of pheochromocytoma and paraganglioma by 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography.

http://www.wikidata.org/entity/Q35925505

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Staging and functional charact ...... positron emission tomography.

@ast

Staging and functional charact ...... positron emission tomography.

@en

type

label

Staging and functional charact ...... positron emission tomography.

@ast

Staging and functional charact ...... positron emission tomography.

@en

prefLabel

Staging and functional charact ...... positron emission tomography.

@ast

Staging and functional charact ...... positron emission tomography.

@en

P1433

Q35925505-65FF61E8-8F47-4A82-83B2-DE89F4077AB3

P1476

Q35925505-80C7E1C5-23AB-4184-ABEC-38B78685894B

P2093

Q35925505-20DF9669-F2AA-410A-8D5A-90D72B52FAB1

Q35925505-20EFD585-8255-4EED-8E46-5FE2E4759555

Q35925505-386A5F4B-B0A9-420F-8757-D65BBE8AE9D7

Q35925505-47AE60CC-90C0-4F66-A272-B1C3691D6089

Q35925505-6CC7E3FC-108F-45CB-9CCB-0358270AA538

Q35925505-835C1D72-364D-4B2E-B015-95FBB1989C52

Q35925505-A8A5F019-AF54-43A0-90EC-5D79EEF41C45

Q35925505-D37FF663-066A-41D8-84E8-87AD940EFED5

Q35925505-D9E5BF26-5C88-4A28-8B9E-0DB13AC1DF46

Q35925505-E6A58831-EEE2-4B70-A690-12D280DB0D5F

P2860

Q35925505-0A0BA5C8-DEF7-4CEE-A20C-DAAF566BC9B6

Q35925505-103A4A55-BDF3-48AB-95B1-C14AE6B5C341

Q35925505-2DBBB975-2FE1-4FA4-8735-6039036DC649

Q35925505-38354CEF-515D-446A-9119-E43B5AF8B6E4

Q35925505-3BCC38FF-FC2A-44EC-A9BC-94F0ECCE9A13

Q35925505-3BF1CC4C-B075-472B-8510-ACACADAA1A38

Q35925505-40732EA0-809F-41CE-A14F-2599A06C64D8

Q35925505-47A9D8D3-C44F-4632-8603-F6EDDCCE40C6

Q35925505-49116967-31BA-41B4-9AF3-2816A59E77C4

Q35925505-4F46C889-736B-44EB-8D2D-A32F1D1A69F7

P304

Q35925505-5718AB3A-C6FF-4EB8-ABCB-313CA6643087

P31

Q35925505-16E63D6D-DD94-4D70-950C-F38358DB7936

P356

Q35925505-714F5843-2FC2-4DED-A5F2-DD734CE102B8

P407

Q35925505-D0BA3103-F7CF-44AF-B38C-DD15E7B9ADA0

P433

Q35925505-3137521E-330B-4AB1-B8E4-94215F444D82

P478

Q35925505-841573F2-3907-456C-AC09-413A973C6C13

P50

Q35925505-E652EE86-4078-4006-8A73-5DEDB479909E

P577

Q35925505-A8F86593-D784-4ED3-8A53-50DCE0F6668E

P5875

Q35925505-285A9C50-0538-47BD-AE00-F772CFC3EE84

P698

Q35925505-1ECB572A-E61C-4A6F-AF67-4552F6A49C49

P921

Q35925505-1839C4C9-BDEA-4D1E-9DCE-5BF18E4D33C3

P932

Q35925505-9FA6BFD0-FD06-4D7C-8C2A-37B300270FFF

P356

P1433

Journal of the National Cancer Institute

P1476

Staging and functional charact ...... positron emission tomography.

@en

P2093

Alexander Ling

http://www.w3.org/2001/XMLSchema#string

Clara C Chen

http://www.w3.org/2001/XMLSchema#string

Graeme Eisenhofer

http://www.w3.org/2001/XMLSchema#string

Henri J L M Timmers

http://www.w3.org/2001/XMLSchema#string

Jorge A Carrasquillo

http://www.w3.org/2001/XMLSchema#string

Jyotsna U Rao

http://www.w3.org/2001/XMLSchema#string

Karen T Adams

http://www.w3.org/2001/XMLSchema#string

Kathryn S King

http://www.w3.org/2001/XMLSchema#string

Millie Whatley

http://www.w3.org/2001/XMLSchema#string

Robert A Wesley

http://www.w3.org/2001/XMLSchema#string

P2860

Germline mutations in TMEM127 confer susceptibility to pheochromocytoma

A HIF1alpha regulatory loop links hypoxia and mitochondrial signals in pheochromocytomas

On the Origin of Cancer Cells

Biochemical diagnosis of pheochromocytoma: which test is best?

Distinct clinical features of paraganglioma syndromes associated with SDHB and SDHD gene mutations

The Warburg effect is genetically determined in inherited pheochromocytomas

SDHA is a tumor suppressor gene causing paraganglioma.

Positron-emission tomography with [18F]fluorodeoxyglucose. Part I. Biochemical uptake mechanism and its implication for clinical studies.

SDHAF2 mutations in familial and sporadic paraganglioma and phaeochromocytoma.

Germ-line mutations in nonsyndromic pheochromocytoma.

P304

700-708

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/JNCI/DJS188

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

104

http://www.w3.org/2001/XMLSchema#string

P50

P577

2012-04-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

224770381

http://www.w3.org/2001/XMLSchema#string

P698

22517990

http://www.w3.org/2001/XMLSchema#string

P921

phaeochromocytoma

P932

3341309

http://www.w3.org/2001/XMLSchema#string